Leprosy
- Leprosy spreads by skin to skin contact and by droplet spread .
- Neurological involvement is pronounced in Tuberculoid type of leprosy .
- Single skin lesion is seen in TT type of leprosy.
- Long contact with tuberculoid leprosy can transmit the disease .
- Slit skin smear, Fine needle aspiration cytology, Skin biopsy are used for diagnosis of Leprosy.
- Lepromin test is not used for the diagnosis of Leprosy.
- In the management of leprosy, lepromin test is most useful for prognosis.
- Exacerbation of lesions in patients of borderline leprosy is seen in Lepra reaction type -I.
- Under leprosy eradication programme the managment of single lesion is Rifampicin, ofloxacin and minocycline single dose.
- Subtype of leprosy with maximum number of TH -1 cells is TT.
- Lepra cells found in lepromatous leprosy are Macrophages.
- In Leprosy most common renal lesion seen is MGN.
- Fastest acting drug in leprosy is Rifampicin.
- Kanamycin is not used in the treatment of leprosy.
- Drug causing icthyosis and hyperpigmentation, when used in leprosy is Clofazimine.
- Most common type of leprosy in India is TT.
- Skin smear is negative in Neuritic,Tuberculoid,Intermediate leprosy.
- Characteristic feature of borderline leprosy is inverted saucer lesion.
- Vesicles are not seen in Leprosy.
- Erythematous Macule, Hypo pigmented patch, Flat & raised patches may be seen in Leprosy.
- Gynaecomastia, Madarosis, Saddle nose, Leonine facies, Loss of libido and impotence are features of lepromatous leprosy.
- Commonest nerve involved in leprosy is Ulnar.
- In leprosy nerves commonly involved are high ulnar and low median.
- Abnormal EMG, voluntary muscle wasting, decreased response to tactile sensation may be seen in Leprosy.
- Decreased Proprioception is not seen in Leprosy.
- Leprosy do not involve CNS, uterus.
- Tuberculoid leprosy is characterised by non-caseating granuloma in nerve.
- Presence of globi, subepidermal free zone, decreased cell mediated immunity can be seen in Lepromatous Leprosy.
- Skin biopsy in leprosy is characterized by pariappendegial bacilli,pariappendegeal lymphocytosis, perivascular lymphocytosis.
- Lepromin test is positive in Tuberculoid leprosy.
- A 27-year-old patient was diagnosed to have borderline leprosy and started on multibacillary multi-drug therapy. Six weeks later, he developed pain in the nerves and redness and swelling of the skin lesions. The management of his illness should include all of the following:Continue Anti-leprosy Drugs,Costicosteroids, Analgesics, Rest to the limb.
- Best method of treatment of ulnar never abscess in case of leprosy is Incision and drainage.
- ENL is seen in LL form of leprosy.
- The first line antileprosy drugs include : Dapsone, Clofazimine, Rifampicin
- Side effect of clofazimine used in leprosy therapy is Hyperpigmentation and Discolouration of body secretions.
- Control of TB and leprosy is by early diagnosis and treatment.
- WHO regime for paucibacillary leprosy:100 mg Dapsone daily + Rifampcin 600 mg monthly.
- Duration of treatment in pauci bacillary leprosy is 6 months.
- Average duration of treatment in multibacillary leprosy is 1 year.
- Prevalence of leprosy is decreasing in past decade in India.
- Insect can transmit Leprosy.
- Transplacental spread is not the mode of transmission of Leprosy.
- “Multibacillary” is a spectrum of disease, seen in Leprosy.
- Ridley jopling leprosy classification is a type of Clinical, bacteriological, immunological, histological classification.
- Lepromin test is negative in most of the child in 1st 6 month of life.
- BCG vaccination converts lepra reaction from negative to positive.
- A patient with leprosy had slightly erythematous, anesthetic plaques on the trunk and upper limbs. He was treated with paucibacillary multidrug therapy (PB-MDT) for 6 months. At the end of 6 months, he had persistent erythema and induration in the plaque. The next step of action recommended by the World Health Organization (WHO) in such a patient is to stop anti-leprosy treatment.
- Treatment of severe ulnar neuritis in borderline tuberculoid leprosy is MDT with steroids.
- For treatment of paucibacillary leprosy drugs used are Rifampicin and Dapsone.
- In multibacillary leprosy the follow up examination after adequate treatment should’be done yearly for 5 years.
- 2 yrs duration in terms of leprosy is with regard to post Rx surveillance of paucibacillary leprosy.
- Immunoprophylaxis of leprosy includes BCG and ICRC bacillus.
- Strategies in National Leprosy control program are early detection of cases; short course multi drug therapy;rehabilitation
- In leprosy eradication programme the multidrug therapy is not long term but short term therapy.
- Effective leprosy control programme may be indicated in : Decreased grade 2 disability,Low MDR resistant, multibacillary cases ,High new case detection rate.
- Elimination of leprosy is defined as prevalance < 1 per 10000.
- As per WHO, leprosy is a public health problem if prevalence is 0.01%.
- SET centres are established if prevalence leprosy is 1-5.
- National Leprosy Eradication Programme was started in 1983.
- Special Action Project for Elimination of leprosy is for rural areas.
- Trophic ulcers may be caused by Leprosy.
- Leprosy may lead to secondary Amyloidosis, Depressed bridge of nose, Septal perforation of nose.
- ‘Iris-pearls’ are seen in Leprosy.
- Ocular lesions of leprosy include : Avascular keratitis ,Interstitial keratitis , Neuroparalytic keratitis.
- Hansen (1874) described leprosy bacillus.
- Thalidomide is useful in treatment of type II lepra reaction.
- Foamy histocytes, Epitheliod cells, Noncaseating granulomas can be seen in histological examination in a case of Leprosy.
- Very numerous, symmetrically distributed, erythematous or copper coloured shiny macules/papule are feature of LL.
- More than 5 lesions on skin smears seen in Multibacillary Leprosy.
- Clofazimine is an important drug to be given in Multibacillary Leprosy.
- Asmmetrical several nerves thickening with several hypoesthetic macules on skin indicates Borderline borderline stage of leprosy.
- Most important in establishing diagnosis of leprosy is Slit smear for AFB.
- Innumerable, small, normoesthetic and symmetrical skin lesions are present in Lepromatous type of leprosy.
- The fingerprint pattern may be impaired permanently in case of Leprosy.
- Globi in leprosy consist of AFB with macrophages.
- Leprosy is not targeted for global eradication because of long incubation period.
- Multiple hypoaesthetic, hypopigmented macules on right lateral forearm with numerous acid fast bacilli is indicative of Borderline Leprosy.
- Patient with leprosy, smear sample taken show 10 – 100 bacilli in one field. Bacterial index is 4+.
- Ulceronecrotic nodule is seen in Lucio Leprosy.
- Nerves are not involved in Indeterminate Leprosy.
- If a claw hand develops in a patient with Leprosy, the deformity is Grade II.
- Most sensitive index of transmission in leprosy is Incidence.
Exam Important
- Leprosy spreads by skin to skin contact and by droplet spread .
- Neurological involvement is pronounced in Tuberculoid type of leprosy .
- Single skin lesion is seen in TT type of leprosy.
- Long contact with tuberculoid leprosy can transmit the disease .
- Slit skin smear, Fine needle aspiration cytology, Skin biopsy are used for diagnosis of Leprosy.
- Lepromin test is not used for the diagnosis of Leprosy.
- In the management of leprosy, lepromin test is most useful for prognosis.
- Exacerbation of lesions in patients of borderline leprosy is seen in Lepra reaction type -I.
- Under leprosy eradication programme the managment of single lesion is Rifampicin, ofloxacin and minocycline single dose.
- Subtype of leprosy with maximum number of TH -1 cells is TT.
- Lepra cells found in lepromatous leprosy are Macrophages.
- In Leprosy most common renal lesion seen is MGN.
- Fastest acting drug in leprosy is Rifampicin.
- Kanamycin is not used in the treatment of leprosy.
- Drug causing icthyosis and hyperpigmentation, when used in leprosy is Clofazimine.
- Most common type of leprosy in India is TT.
- Skin smear is negative in Neuritic,Tuberculoid,Intermediate leprosy.
- Characteristic feature of borderline leprosy is inverted saucer lesion.
- Vesicles are not seen in Leprosy.
- Erythematous Macule, Hypo pigmented patch, Flat & raised patches may be seen in Leprosy.
- Gynaecomastia, Madarosis, Saddle nose, Leonine facies, Loss of libido and impotence are features of lepromatous leprosy.
- Commonest nerve involved in leprosy is Ulnar.
- In leprosy nerves commonly involved are high ulnar and low median.
- Abnormal EMG, voluntary muscle wasting, decreased response to tactile sensation may be seen in Leprosy.
- Decreased Proprioception is not seen in Leprosy.
- Leprosy do not involve CNS, uterus.
- Tuberculoid leprosy is characterised by non-caseating granuloma in nerve.
- Presence of globi, subepidermal free zone, decreased cell mediated immunity can be seen in Lepromatous Leprosy.
- Skin biopsy in leprosy is characterized by pariappendegial bacilli,pariappendegeal lymphocytosis, perivascular lymphocytosis.
- Lepromin test is positive in Tuberculoid leprosy.
- A 27-year-old patient was diagnosed to have borderline leprosy and started on multibacillary multi-drug therapy. Six weeks later, he developed pain in the nerves and redness and swelling of the skin lesions. The management of his illness should include all of the following:Continue Anti-leprosy Drugs,Costicosteroids, Analgesics, Rest to the limb.
- Best method of treatment of ulnar never abscess in case of leprosy is Incision and drainage.
- ENL is seen in LL form of leprosy.
- The first line antileprosy drugs include : Dapsone, Clofazimine, Rifampicin
- Side effect of clofazimine used in leprosy therapy is Hyperpigmentation and Discolouration of body secretions.
- Control of TB and leprosy is by early diagnosis and treatment.
- WHO regime for paucibacillary leprosy:100 mg Dapsone daily + Rifampcin 600 mg monthly.
- Duration of treatment in pauci bacillary leprosy is 6 months.
- Average duration of treatment in multibacillary leprosy is 1 year.
- Prevalence of leprosy is decreasing in past decade in India.
- Insect can transmit Leprosy.
- Transplacental spread is not the mode of transmission of Leprosy.
- “Multibacillary” is a spectrum of disease, seen in Leprosy.
- Ridley jopling leprosy classification is a type of Clinical, bacteriological, immunological, histological classification.
- Lepromin test is negative in most of the child in 1st 6 month of life.
- BCG vaccination converts lepra reaction from negative to positive.
- A patient with leprosy had slightly erythematous, anesthetic plaques on the trunk and upper limbs. He was treated with paucibacillary multidrug therapy (PB-MDT) for 6 months. At the end of 6 months, he had persistent erythema and induration in the plaque. The next step of action recommended by the World Health Organization (WHO) in such a patient is to stop anti-leprosy treatment.
- Treatment of severe ulnar neuritis in borderline tuberculoid leprosy is MDT with steroids.
- For treatment of paucibacillary leprosy drugs used are Rifampicin and Dapsone.
- In multibacillary leprosy the follow up examination after adequate treatment should’be done yearly for 5 years.
- 2 yrs duration in terms of leprosy is with regard to post Rx surveillance of paucibacillary leprosy.
- Immunoprophylaxis of leprosy includes BCG and ICRC bacillus.
- Strategies in National Leprosy control program are early detection of cases; short course multi drug therapy;rehabilitation
- In leprosy eradication programme the multidrug therapy is not long term but short term therapy.
- Effective leprosy control programme may be indicated in : Decreased grade 2 disability,Low MDR resistant, multibacillary cases ,High new case detection rate.
- Elimination of leprosy is defined as prevalance < 1 per 10000.
- As per WHO, leprosy is a public health problem if prevalence is 0.01%.
- SET centres are established if prevalence leprosy is 1-5.
- National Leprosy Eradication Programme was started in 1983.
- Special Action Project for Elimination of leprosy is for rural areas.
- Trophic ulcers may be caused by Leprosy.
- Leprosy may lead to secondary Amyloidosis, Depressed bridge of nose, Septal perforation of nose.
- ‘Iris-pearls’ are seen in Leprosy.
- Ocular lesions of leprosy include : Avascular keratitis ,Interstitial keratitis , Neuroparalytic keratitis.
- Hansen (1874) described leprosy bacillus.
- Thalidomide is useful in treatment of type II lepra reaction.
- Foamy histocytes, Epitheliod cells, Noncaseating granulomas can be seen in histological examination in a case of Leprosy.
- Very numerous, symmetrically distributed, erythematous or copper coloured shiny macules/papule are feature of LL.
- More than 5 lesions on skin smears seen in Multibacillary Leprosy.
- Clofazimine is an important drug to be given in Multibacillary Leprosy.
- Asmmetrical several nerves thickening with several hypoesthetic macules on skin indicates Borderline borderline stage of leprosy.
- Most important in establishing diagnosis of leprosy is Slit smear for AFB.
- Innumerable, small, normoesthetic and symmetrical skin lesions are present in Lepromatous type of leprosy.
- The fingerprint pattern may be impaired permanently in case of Leprosy.
- Globi in leprosy consist of AFB with macrophages.
- Leprosy is not targeted for global eradication because of long incubation period.
- Multiple hypoaesthetic, hypopigmented macules on right lateral forearm with numerous acid fast bacilli is indicative of Borderline Leprosy.
- Patient with leprosy, smear sample taken show 10 – 100 bacilli in one field. Bacterial index is 4+.
- Ulceronecrotic nodule is seen in Lucio Leprosy.
- Nerves are not involved in Indeterminate Leprosy.
- If a claw hand develops in a patient with Leprosy, the deformity is Grade II.
- Most sensitive index of transmission in leprosy is Incidence.
Don’t Forget to Solve all the previous Year Question asked on Leprosy
Click Here to Start Quiz
Click Here to Start Quiz
